by rss feed | Jul 8, 2025 | ALS, BrainStorm Cell Therapeutics, News Feeds, NurOwn
ALS is a devastating, incurable disease that urgently needs innovative treatments and cell therapies have potential, but so far data on the most prominent candidate cellular drug, Nurown from BrainStorm Cell Therapeutics, have not convinced the FDA to approve it. The...
by rss feed | Sep 26, 2023 | ALS, BrainStorm Cell Therapeutics, FDA, News Feeds, NurOwn
BrainStorm Cell Therapeutics is developing Nurown, an investigational therapy intended for treating ALS. I recently posted about BrainStorm and its prospects for providing real hope on stem cells for ALS. I see it as a long shot. The ALS community needs real hope, but...
by rss feed | Feb 22, 2023 | ALS, BrainStorm Cell Therapeutics, Informational, News Feeds, NurOwn
What is the cell therapy for ALS called NurOwn? How strong is its potential as a treatment for ALS? I’ve been following the biotech BrainStorm Cell Therapeutics for many years. Patients keep asking me about NurOwn ALS prospects. They’re looking for hope....
by rss feed | Nov 13, 2022 | BrainStorm Cell Therapeutics, News Feeds, NurOwn
I get a lot of questions about stem cells for ALS and more recently people have been specifically interested in NurOwn from BrainStorm Cell Therapeutics. Recently, the FDA denied BrainStorm’s request for a BLA for NurOwn. The company felt its Phase III trial was...
